A Phase 2 Trial of Primary Tumor Stereotactic Body Radiation Therapy Boost Before Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer

医学 肿瘤科 放射治疗 肺癌 内科学 放射科
作者
Terence M. Williams,Eric D. Miller,M.X. Welliver,Jeremy Brownstein,Gregory A. Otterson,Dwight H. Owen,Karl Haglund,Peter G. Shields,Erin M. Bertino,Carolyn J. Presley,Kai He,Jacob Naduparambil,Steve Walston,Xueliang Pan,Xiangyu Yang,Michael V. Knopp,Jean Koutou Essan,Joseph P. McElroy,Xiaokui Mo,Sohyun L. McElroy
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier BV]
卷期号:120 (3): 681-694 被引量:4
标识
DOI:10.1016/j.ijrobp.2024.02.020
摘要

ABSTRACT

BACKGROUND

Primary tumor failure is common in patients treated with chemoradiation (CRT) for locally-advanced NSCLC (LA-NSCLC). Stereotactic body radiation therapy (SBRT) yields high rates of primary tumor control (PTC) in early-stage NSCLC. This trial tested an SBRT boost to the primary tumor prior to the start of CRT to improve PTC.

MATERIALS/METHODS

Patients with LA-NSCLC received an SBRT boost in 2 fractions (central location 12 Gy, peripheral location 16 Gy) to the primary tumor, followed by standard CRT (60 Gy in 30 fractions). The primary objective was PTC rate at 1-year with a hypothesis that the 1-year PTC rate is ≥90%. Secondary objectives included objective response rate (ORR), regional & distant control, disease-free survival (DFS), and overall survival (OS). Correlative studies included functional MRI (fMRI) and blood-based miRNA analysis.

RESULTS

The study enrolled 21 patients (10 male, 11 female), with median age 62 years (range 52-78). Median pre-treatment primary tumor size was 5.0 cm (range 1.0-8.3). The most common non-hematologic toxicities were pneumonitis, fatigue, esophagitis/dysphagia, dyspnea, and cough. Only 1 treatment-related grade 4 non-hematologic toxicity occurred (respiratory failure/radiation pneumonitis), and there were no grade 5 toxicities. ORR at 3 and 6 months was 72.7% and 80.0%, and PTC at 1 and 2 years was 100% and 92.3%, respectively. The 2-year regional and distant control were 81.6% and 70.3%, respectively. DFS and OS at 2 yrs were 46.1% and 50.3%, respectively. Median survival was 37.8 months. fMRI detected a mean relative decrease in BOLD signal of -87.1% (p=0.05), and miR.142.3p correlated with increased risk of grade≥3 pulmonary toxicity (p=0.01).

CONCLUSIONS

Dose escalation to the primary tumor utilizing upfront SBRT appears feasible and safe. PTC was high and other oncologic endpoints compared favorably to standard treatment. fMRI suggested changes in oxygenation with the first SBRT boost dose, and miR.142.3p correlated with pulmonary toxicity.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
量子星尘发布了新的文献求助10
1秒前
Minicoper发布了新的文献求助10
1秒前
背书强完成签到 ,获得积分10
2秒前
淡然以柳完成签到 ,获得积分10
4秒前
dolabmu完成签到 ,获得积分10
7秒前
崔崔完成签到 ,获得积分10
11秒前
SYLH应助xcxc采纳,获得10
12秒前
wp4455777完成签到,获得积分10
13秒前
十一完成签到,获得积分10
13秒前
ru完成签到 ,获得积分10
15秒前
慧木完成签到 ,获得积分10
15秒前
WW完成签到 ,获得积分10
16秒前
小高同学完成签到,获得积分10
17秒前
轻轻1完成签到,获得积分10
20秒前
21秒前
大橙子发布了新的文献求助10
25秒前
iuhgnor完成签到,获得积分10
28秒前
可夫司机完成签到 ,获得积分10
31秒前
yang完成签到,获得积分10
33秒前
一1完成签到 ,获得积分10
35秒前
jiaolulu完成签到,获得积分10
35秒前
量子星尘发布了新的文献求助10
37秒前
爆米花应助LiZhao采纳,获得10
37秒前
轻轻完成签到,获得积分10
40秒前
Orange应助jiaolulu采纳,获得10
40秒前
xcxc完成签到,获得积分10
42秒前
water应助科研通管家采纳,获得50
42秒前
42秒前
默存完成签到,获得积分10
45秒前
风中的金鱼完成签到 ,获得积分10
47秒前
橙汁完成签到,获得积分10
48秒前
普鲁卡因发布了新的文献求助10
51秒前
cora完成签到 ,获得积分10
57秒前
徐伟康完成签到 ,获得积分10
57秒前
Minicoper完成签到,获得积分10
1分钟前
科研通AI5应助普鲁卡因采纳,获得10
1分钟前
111完成签到 ,获得积分10
1分钟前
奥特曼完成签到 ,获得积分10
1分钟前
苏苏完成签到,获得积分10
1分钟前
大橙子完成签到,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038128
求助须知:如何正确求助?哪些是违规求助? 3575831
关于积分的说明 11373827
捐赠科研通 3305610
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022